Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial

Acid suppressing agents are widely used to treat the iatrogenic ulcers following endoscopic mucosal resection for gastric neoplasms. However, the relative merits of proton pump inhibitor or histamine2‐receptor antagonist for endoscopic mucosal resection‐induced ulcers are not known.

[1]  K. Chayama,et al.  The Effect of Helicobacter Pylori Eradication Therapy on Gastric Ulcer Healing After Endoscopic Mucosal Resection , 2006, Journal of clinical gastroenterology.

[2]  M. Miura,et al.  A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection‐induced ulceration , 2005, Alimentary pharmacology & therapeutics.

[3]  S. Paik,et al.  Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. , 2004, Gastrointestinal endoscopy.

[4]  M. Fujishima,et al.  Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans , 2002, European journal of gastroenterology & hepatology.

[5]  C. Marra,et al.  Meta-Analysis of Proton Pump Inhibitors in Treatment of Bleeding Peptic Ulcers , 2001, The Annals of pharmacotherapy.

[6]  J. Gisbert,et al.  Proton pump inhibitors versus H2‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer , 2001, Alimentary pharmacology & therapeutics.

[7]  C. Perng,et al.  A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. , 1998, Archives of internal medicine.

[8]  C. Schmid,et al.  Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis. , 1997, Clinical therapeutics.

[9]  Á. Artal,et al.  Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. , 1995, Journal of Clinical Gastroenterology.

[10]  Irvine Ej.  Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. , 1995 .

[11]  K. Plein,et al.  Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. , 1995, Scandinavian journal of gastroenterology.

[12]  E. Umegaki,et al.  Suppressive Action of Lansoprazole on Gastric Acidity and Its Clinical Effect in Patients with Gastric Ulcers: Comparison with Famotidine , 1995, Journal of clinical gastroenterology.

[13]  R. Kleinert,et al.  Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration , 1992, Alimentary pharmacology & therapeutics.

[14]  C. Howden,et al.  Omeprazole. Overview and opinion. , 1991, Digestive diseases and sciences.

[15]  Omeprazole 20 mg uid and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Italian Cooperative Group on Omeprazole. , 1991, Hepato-Gastroenterology.

[16]  G. Brunner,et al.  Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial. , 1990, Digestion.

[17]  C. Bate,et al.  Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. , 1989, Gut.

[18]  M. Classen,et al.  Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. , 1989, The New England journal of medicine.

[19]  H. Wulff,et al.  Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. , 1988, Gut.

[20]  J. Rask-Madsen,et al.  Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. , 1985, The New England journal of medicine.

[21]  E. C. Wood,et al.  Effect of daily oral omeprazole on 24 hour intragastric acidity. , 1983, British medical journal.